Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab
Sponsor: Jonsson Comprehensive Cancer Center